ENDRA Life Sciences Inc. NDRA
Set alert
4.80 USD +0.05 +1.05%
At close
4.49 -0.31 -6.46%
Pre-market · Nov 3, 5:17 AM ET
4.64 Day range 4.89
2.96 52-week range 6.95
- YTD
- +5.96%
- 1 year
- -7.16%
- Open
- 4.64
- Prev close
- 4.75
- Mkt cap
- 7.20M
- Vol
- 5.78K
- Avg vol
- 30.79K
- EPS
- -6.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.64
- High
- 4.89
- Forward P/E
- -0.02
- Beta
- 0.74
- Short ratio
- 0.05
- Inst. own
- 0.49%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.68
- 200-d avg
- 291.96
- 1y target
- 2,625.00
15m chart
Built from the cached five-day intraday bars.
Signals (36)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 10:35 AM | 21 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 21 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 21 hours ago |
| RSI: Oversold | Nov 2, 9:50 AM | 22 hours ago |
| MACD: Sell Signal | Oct 30, 3:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 11:45 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:45 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:45 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 4:00 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 3:45 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:15 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:15 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:30 PM | 4 days ago |
| SMA: Bearish | Oct 29, 1:30 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:00 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:00 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 12:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:45 AM | 4 days ago |
Newest 20 of 36.
Financial health
Altman Z-Score
-19.45 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -0.5×
FY 2016 5y median -630× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.6×
FY 2016 5y median 1120× FY 2025
P/FCF -0.7×
FY 2016 5y median -661× FY 2025
EV/EBITDA -0.5×
FY 2016 5y median -647× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -145.8%
FY 2016 5y median -0.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -310.9%
FY 2016 5y median -182.9% FY 2025
ROIC -178.3%
FY 2016 5y median -173.8% FY 2025
ROA -182.4%
FY 2016 5y median -148.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 46.7%
FY 2016 FY 2025
EPS (diluted) 12.9%
FY 2016 FY 2025
Free Cash Flow 29.9%
FY 2016 FY 2025
Financial Health
Current Ratio 1.3×
FY 2016 5y median 5.0× FY 2025
Quick Ratio 1.3×
FY 2016 5y median 3.5× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median -0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
